Plenitude, a benefit company that belongs to Milan-listed energy giant Eni, is mulling for investing 500-700 million euros for the acquisition of Acea Energia (see here a previous post by BeBeez). Plenitude could also sell a 15%. The stake is of interest to Apollo Global Management, Ares Management, Stonepeak, Trilantic Europe, and HitecVision.
KKR acquired a further 5% Enilive (a subsidiary of Milan-listed energy giant Eni) for 587.5 million euros (see here a previous post by BeBeez). The fund closed the deal on the ground of a post-money equity value of 11.75 billion. KKR’s 30% of Enilive has a current book value of 3.52 billion.
On 18 February, Tuesday, CVC Capital Partners, PSP Investments, StepStone, and Alpinvest, 51.82% owners of Milan-listed pharma company Recordati, started an accelerated bookbuilding (ABB) procedure for selling 5% and fetched 55,70 euros per share for a total of 585 million euros (see here a previous post by BeBeez). Goldman Sachs, JP Morgan and Deutsche Bank assisted CVC and its co-investors that now own 46.82% of Recordati. BeBeez Private Data, the private capital database of BeBeez and FSI, monitors CVC and its Italian portfolio companies. Find out here how to subscribe for one month or one year or Click here for booking a demo videocall with BeBeez database manager
PIB Group, an UK insurance broker that belongs to Apax and The Carlyle Group, said it acquired Italian competitor Elleti Broker (see here a previous post by BeBeez). After such a deal, PIB’s Italian branch will have a turnover of above 35 million euros. Giuseppe Tirelli founded Elleti Broker in 2012 and will keep his management role. Onno Janssen is the ceo of PIB Group Europe. BeBeez Private Data, the private capital database of BeBeez and FSI, monitors Apax, Carlyle and their Italian portfolio companies. Find out here how to subscribe for one month or one year or Click here for booking a demo videocall with BeBeez database manager
Ibla Capital acquired BorgWarner Systems Lugo, an Italian producer of industrial components, from USA’s BorgWarner and received assistance from NCTM Advant, PwC TLS, Deloitte Financial Advisory, Audirevi, and Studio Noventa (see here a previous post by BeBeez). Tha target has sales of 61.1 million euros, an ebitda of 14.2 million and hasn’t any net financial debt. Alessandro Lo Savio is the founder of Ibla Capital. BeBeez Private Data, the private capital database of BeBeez and FSI, monitors and its portfolio companies. Find out here how to subscribe for one month or one year or Click here for booking a demo videocall with BeBeez database manager
F2i will sell of its 40% in Iren Acqua, an asset that purchased in 2010 from Veolia and through a delisting from Milan market, to the mother company Iren that already 60% of the target (see here a previous post by BeBeez). Rothschild & Co is assisting Iren that will pay 100 million at the closing and 182.5 million in 4.25 years with a 4.5% passive rate BeBeez Private Data, the private capital database of BeBeez and FSI, monitors F2i and its portfolio companies. Find out here how to subscribe for one month or one year or Click here for booking a demo videocall with BeBeez database manager
The financials of FiberCop, a joint venture that Milan-listed TIM formerly signed with KKR, are unclear, UK’s Financial Times reported (see here a previous post by BeBeez). The paper quoted FiberCop’s cfo Gabriele Mandurino as saying to investors on 16 January, Thursday, that the company’s ebitda for 2025 will be EUR 449 million euros lower than KKR’s business plan expected. The 5-years cumulative ebitda would now amount to 2 billion. The company may not pay dividends. FiberCop strongly denied such claims.
CVC Capital Partners will acquire a further 10% of Italian system integrator Maticmind of which already owns a 75% while CDP Equity currently has 15% of the business, sources said to BeBeez and further press items reported (see here a previous post by BeBeez). The founder Carmine Saladino is willing to sell his stake. Maticmind has sales of 448 million euros with a 51 million ebitda.
Polifarma acquired Hennig Arzneimittel Gmbh &Co. KG, a German CDMO (contract development and manufacturing organization) (see here a previous post by BeBeez). Banca Patrimoni Sella & C. financed the transaction. Deloitte Financial Advisory and EY Law assisted Polifarma. Hennig retained RSM Ebner Stolz. Loan Agency Services acted as transaction agent. The target has sales in the region of 60 million euros.
